Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

Share Price is delayed by 15 minutes
Get Live Data
7.90    -0.50 (-5.95%)
Bid:
7.80
Ask:
8.00
Spread: 0.20 (2.564%)
Market Cap: £27.81m
CYAN Live PriceLast checked at - London Stock Exchange

Intraday Cyanconnode Share Chart

Form 8 (Opening Position Disclosure) - Replacement

5 Mar 2026 16:17

RNS Number : 5614V
CyanConnode Holdings PLC
05 March 2026
 

Replacement: This announcement replaces the "CyanConnode Holdings plc - Form 8 (OPD)" announcement released at 12:52:13 on 17 February 2026 with RNS Number 3736T. The interests disclosed in respect of Peter Tyler, his close relatives and related trusts have been amended. All other information, save for the date of disclosure, remains unchanged.

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

CyanConnode Holdings plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CyanConnode Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

16 February 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 2 pence each

("Ordinary Shares")

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Directors' interests

a) Ordinary Shares held by the directors of CyanConnode Holdings plc, their close relatives and related trusts:

Director

Number of Ordinary Shares held

Percentage of total issued ordinary share capital

Peter Tyler and associated persons

21,199,227*

5.90

William David Johns-Powell

19,621,561

5.47

John Cronin

13,062,451**

3.64

Heather Peacock

2,822,966***

0.79

Bjorn Lindblom

912,377

0.25

Lyndon Faulkner

500,000

0.14

Notes:

* - includes 723,794 ordinary shares held by his daughter, Jessica Pullen; 4,407,556 shares held personally by his brother, Barrie Tyler, together with 13,224,837 shares held by Nathan Tyler and Simon Tyler (sons of Barrie Tyler) and their close relatives (excluding Barrie Tyler), who also hold 2,217,700 cash-settled derivatives; and 236,389 shares held by his brother Andrew Tyler, together with Andrew's wife, Sharon Tyler

** - includes 5,672,359 shares held jointly with the CyanConnode Holdings plc Employee Benefit Trust ("EBT") pursuant to a Joint Share Ownership Plan ("JSOP")

*** - includes 1,331,498 shares held jointly with the EBT pursuant to a JSOP

 

b) Ordinary Shares held by entities connected with the directors of CyanConnode Holding plc

 

Number of Ordinary Shares held

Percentage of total issued ordinary share capital

Albert E Sharp LLP *

2,279,241

0.63

Notes:

* - Albert E Sharp LLP is a firm in which Peter Tyler's brother, Barrie Tyler, is a partner, and exercises discretion over 2,279,241 of the 6,219,180shares held by the firm under discretion.

 

c) Options or awards granted under the share plans of CyanConnode Holdings plc held by the directors of CyanConnode Holdings plc, their close relatives and related trusts:

 

Name

Name of Share Option Scheme

Number of Options

Exercise Price

(£)

Grant Date

Vesting Date

Expiry Date

Vesting Status

William David Johns-Powell

Unapproved

250,000

0.1000

28/09/20

28/09/24

28/09/30

Vested

Heather Peacock

Unapproved

25,000

0.4000

11/12/17

11/12/21

11/12/27

Vested

Unapproved

90,909

0.1000

22/09/20

22/09/24

22/09/30

Vested

Unapproved

100,000

0.1575

17/11/23

17/11/23

17/11/33

Vested

Unapproved

100,000

0.1575

17/11/23

31/03/24

17/11/33

Vested

Unapproved

100,000

0.1575

17/11/23

31/03/25

17/11/33

Vested

Unapproved

68,021

0.1400

17/11/23

17/11/23

17/11/33

Vested

Unapproved

68,021

0.1400

17/11/23

31/03/24

17/11/33

Vested

Unapproved

68,023

0.1400

17/11/23

31/03/25

17/11/33

Vested

Unapproved

59,525

0.1700

17/11/23

31/01/24

17/11/33

Vested

Unapproved

59,525

0.1700

17/11/23

31/01/25

17/11/33

Vested

Unapproved

59,527

0.1700

17/11/23

31/01/26

17/11/33

Vested

EMI

266,291

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

266,291

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

266,293

0.1450

10/11/21

30/06/23

10/11/31

Vested

EMI

206,474

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

206,474

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

206,476

0.1450

10/11/21

30/06/23

10/11/31

Vested

John Cronin

EMI

200,000

0.2960

25/01/18

25/01/22

25/01/28

Vested

EMI

360,342

0.1000

22/09/20

22/09/24

22/09/30

Vested

Unapproved

200,000

0.1575

17/11/23

17/11/23

17/11/33

Vested

Unapproved

200,000

0.1575

17/11/23

31/03/24

17/11/33

Vested

Unapproved

200,000

0.1575

17/11/23

31/03/25

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

17/11/23

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

31/03/24

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

31/03/25

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/24

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/25

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/26

17/11/33

Vested

EMI

196,345

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

196,345

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

196,347

0.1450

10/11/21

30/06/23

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/23

10/11/31

Vested

Unapproved

315,689

0.0950

10/10/24

10/10/28

10/10/34

Unvested*

Lyndon Faulkner

EMI

474,833

0.1053

11/11/24

01/11/25

11/11/34

Unvested

EMI

474,833

0.1053

11/11/24

01/11/26

11/11/34

Unvested

EMI

474,833

0.1053

11/11/24

01/11/27

11/11/34

Unvested

EMI

474,836

0.1053

11/11/24

01/11/28

11/11/34

Unvested*

EMI

500,000

0.0994

20/11/24

20/11/28

20/11/34

Unvested*

Peter Tyler

Unapproved

40,000

0.1000

22/09/20

22/09/24

22/09/30

Vested

 

 

Notes:

* - these unvested options include provisions accelerating vesting on a change of control.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 March 2026

Contact name:

Heather Peacock, Chief Financial Officer

Telephone number:

+44 (0)1223 865 750

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEJAMFTMTBMBTF
Date   Source Headline
22nd Oct 20257:09 amRNSTrading Statement
29th Sep 20257:00 amRNSHolding(s) in Company
21st Aug 20253:50 pmRNSResult of AGM
5th Aug 20257:00 amRNSContract in the Middle East and North Africa
30th Jul 20257:00 amRNSNotice of AGM
23rd Jul 20257:00 amRNSFinal Results
22nd Jul 20255:36 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSUpdate on Goa Project and Convertible Loan Note
2nd Jun 20257:00 amRNSUpdate on Goa Contract
20th May 20257:00 amRNSUS$7.5 million Convertible Loan Note
12th May 20257:00 amRNSLetter of Award
9th May 20257:00 amRNSDirectorate Change
28th Apr 20257:00 amRNSTrading Statement
14th Apr 20257:00 amRNS£70m AMISP Milestone Contract
19th Mar 20257:00 amRNSAxia Investments Provides £5 Million Growth Loan
4th Mar 20257:00 amRNSSignificant Follow-On Orders from Montecarlo
26th Nov 20247:00 amRNSHolding(s) in Company
22nd Nov 20247:00 amRNSHolding(s) in Company
20th Nov 20248:00 amRNSHolding(s) in Company
20th Nov 20247:00 amRNSDirector Share Purchase and Issue of Options
13th Nov 20245:15 pmRNSHolding(s) in Company
11th Nov 20245:00 pmRNSDirector Share Options
11th Nov 20247:00 amRNSAppointment of Non-Executive Director
8th Nov 20247:00 amRNSInterim Results
28th Oct 20247:00 amRNSContract in the Middle East and North Africa
10th Oct 20249:30 amRNSDirector Share Options
27th Sep 20249:45 amRNSHolding(s) in Company
26th Sep 20247:00 amRNSDirector Share Purchase
13th Sep 20242:45 pmRNSHolding(s) in Company
10th Sep 20247:47 amRNSResult of oversubscribed Placing and Subscription
9th Sep 20246:21 pmRNSProposed Placing and Subscription
28th Aug 20247:00 amRNSMajor New Contract For 6.5m Omnimesh Modules
22nd Aug 20241:30 pmRNSResult of AGM
1st Aug 20241:45 pmRNSStatement re media speculation
25th Jul 20247:00 amRNSFinal Results
17th Jul 20247:00 amRNSIndian Subsidiary Achieves Key Milestones
27th Jun 20247:00 amRNSEmpanelment Of Digismart For Cellular Deployments
22nd May 20247:00 amRNSEmpanelment of CYAN India Subsidiary as an AMISP
21st May 20247:00 amRNSInvestor Presentation via Investor Meet Company
18th Apr 20247:00 amRNSAppointment of Joint Broker
17th Apr 20241:56 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
15th Apr 20247:00 amRNSOrder For A New Deployment In India
12th Apr 20247:00 amRNSMiddle East Energy Leadership Summit 2024
15th Jan 20247:00 amRNSAppointment of Non-Executive Director
11th Jan 20247:00 amRNSOrder For One Million Omnimesh Modules
27th Dec 20234:18 pmRNSDirector Dealing
19th Dec 20237:00 amRNSInterim Results
6th Dec 20231:32 pmRNSChange of Registered Office
1st Dec 20234:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.